.png)
llluminate: Precision Medicine
North Star ALS’ four-part series brings together researchers, clinicians, and people with lived experience to talk about the science behind more targeted ALS treatments and where the field is headed. Join us!
There’s no cost to join. Come learn with us.
- Conversations spanning genetics, biomarkers, and lived experience
- Real voices from people navigating ALS
- Content you can revisit and share anytime, anywhere
Webinars
We will offer four webinars panel discussions that bring together different perspectives on how precision medicine is shaping ALS research.
Explore topics
Podcasts
Deep conversations, each on a single topic relevant to precision medicine, from genetics to biomarkers to the lived experience.
Learn more
Social Media
Daily dose of educational content, keeping the conversation going, breaking down the science into clear, shareable pieces.
Follow us on Instagram
Sign up below for the webinar series
This series explores the emerging role of precision medicine in ALS, helping the community build a shared understanding of the science shaping the next generation of treatments.
.png)
Introduction to Precision Medicine
Why Biology Matters
What is and what is not precision medicine? Experts from ALS, oncology, and drug development share what it really takes to build better treatments: the biology, the lessons from cancer, the promise and limits of biomarkers, and who research leaves out.
The Lived Experience
The Human Side of Science
Behind every diagnosis is a person. This session gives voice to patients and caregivers navigating research and genetics, from families carrying known genetics to those with sporadic disease. It honors the weight of inherited risk, the uncertainty of a cause that can't be named, and the hope and challenges that run through both.
Research & Industry
Building Precision Therapies
An honest look at how precision therapies are actually built, funded, and moved toward patients. Researchers and industry discuss treatments built for a single patient to those targeting biology shared by most of the disease. The panel explores what makes these approaches different and how the right therapeutic tool gets matched to the right biology.
The Pipeline
Looking Ahead
Our closing panel asks where ALS research and therapeutics are heading: how we might identify and treat ALS earlier, what more targeted drugs mean for the care of patients and those at risk, and the datasets that are the engine behind it all. We'll look at the progress underway and the challenges ahead in reaching everyone living with and at risk for ALS.
About the Podcast
The Illuminate: Precision Medicine Podcast features deep-dives about precision medicine in ALS. Each episode explores one critical topic through honest conversation, whether with a scientist, a clinician, or someone with lived experience.
What to expect:
- Conversations spanning genetics, biomarkers, and lived experience
- Real voices from people navigating ALS
- Content you can revisit and share anytime, anywhere
Soon available on: Apple Podcasts, Spotify and Youtube
With gratitude to our sponsors
%2010.png)
%207.png)
%203.png)
%204.png)
%205.png)
%206.png)
Partner Organizations
%208.png)
%209.png)